Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Israel

Research and Innovation Action · Running

LUCIA Understanding Lung Cancer related risk factors and their Impact

Coordinator
Technion - Israel Institute of Technology, Israel
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€13.5m
Total cost
€13.5m
Partners
24 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101096473

What the project is doing

In the project's own words, from its summary on CORDIS.

Lung Cancer (LC) is the biggest cancer killer worldwide, with five-year survival following diagnosis varying between 5% to 25%. Though tobacco smoking has long been recognized as the major risk factor for LC, many cases (incl. LC patients that are non-smokers) cannot be explained by this reason. In this sense, LUCIA aims to establish a novel toolbox for discovering and understanding new risk factors that contribute to LC development.

The toolbox encompasses the analysis of three aspects: (i) personal risk factors, which include a person’s exposure to chemical pollutants and behavioural and lifestyle factors; (ii) external risk factors, such as urban, built and transport environments, social aspects and climate; and (iii) biological responses to the personal and external risk factors, including changes in genetics, epigenetics, metabolism and aging.

Key components of the toolbox for analysing personal and external risk factors include retrospective and prospective cohort databases, AI models, wearable devices, novel non-invasive sensors, and multi-omics. Together, these tools will be used to identify the effects of a wide range of environmental, biological, demographic, community and individual-level risk factors associated with the formation of LC. Molecular changes associated with the risk factors identified by this set of tools will then be validated by cell and molecular biology methods and through in vivo analysis.

The impact of the identified personal and external risk factors and the associated biological responses will be then validated in three clinical use cases: general population risk assessment and screening, precision screening of high-risk populations, and digital diagnostics. The resulting evidence within LUCIA will be translated into policymaking recommendations, with the aim to implement them in a screening program for LC.

This action is part of the Cancer Mission cluster of projects on ‘Understanding'.

Topics

Who is involved

OrganisationCityCountryRole
Technion - Israel Institute of TechnologyHaifaIsraelCoordinator
Centre Hospitalier Universitaire De LiegeLiegeBelgiumParticipant
European Hospital and Healthcare FederationBruxelles / BrusselBelgiumParticipant
TimelexBruxelles / BrusselBelgiumParticipant
Deutsches Krebsforschungszentrum HeidelbergHeidelbergGermanyParticipant
Ruprecht-Karls-Universitaet HeidelbergHeidelbergGermanyParticipant
Asociacion Instituto De Investigacion Sanitaria BiobizkaiaBarakaldo BizkaiaSpainParticipant
Bilbomatica SABilbaoSpainParticipant
Consorcio Para La Explotacion Del Centro Nacional De Analisis GenomicoBarcelonaSpainParticipant
Fundacio Centre De Regulacio GenomicaBarcelonaSpainParticipant
Fundacio Institut De Recerca Biomedica (irb Barcelona)BarcelonaSpainParticipant
Fundacion Centro De Tecnologias De Interaccion Visual Y Comunicaciones VicomtechDonostia San SebastianSpainParticipant
Fundacion Para La Gestion De La Investigacion En Salud De SevillaSevillaSpainThird party
Servicio Andaluz De SaludSevillaSpainParticipant
Servicio Vasco de Salud OsakidetzaVitoria-GasteizSpainThird party
Universidad Politecnica De MadridMadridSpainParticipant
Nanose Medical LtdNetanyaIsraelParticipant
Pronat Indutries LtdEmek HeferIsraelParticipant
Technion Research and Development Foundation LtdHaifaIsraelThird party
DEXAI - Etica ArtificialeRomaItalyParticipant
Latvijas UniversitateRigaLatviaParticipant
Yaghma B.v.DelftNetherlandsParticipant
Emoda Yazilim Ve Danismanlik Sanayiticaret Limited SirketiİzmirTürkiyeParticipant
University of UlsterColeraineUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI